Singapore's Juniper Biologics secures $600 million licensing deal from Kolon to commercialize cell-mediated gene therapy for degenerative arthritis.

… ] SEOUL -- Juniper Biologics, a Singapore-based developer of novel therapies … be a validation of our technology and its market value,…